The <i>BRAF</i> V600E mutation is a predictor of the effect of radioiodine therapy in papillary thyroid cancer
Junshang Ge(Central South University), Zhaoyang Zeng(TCM-Intigrated Cancer Center of Southern Medical University), Zhao Jin(Hunan Cancer Hospital), Yongzhen Mo(Central South University), Guiyuan Li(Xuzhou Medical College), Xiaoling Li(University of Science and Technology of China), Jie Wang(Fujian Medical University), Hui Wang(Hunan Cancer Hospital), Wei Xiong(Central South University), Qian Gong(Central South University), Xianjie Jiang(Central South University), Qianjin Liao(Hunan Normal University)
Cited by 76
Related Papers
The cancer metabolic reprogramming and immune response
|Molecular Cancer|2021|1.3k
Circular RNAs function as ceRNAs to regulate and control human cancer progression
|Molecular Cancer|2018|1.1k
Neoantigen vaccine: an emerging tumor immunotherapy
|Molecular Cancer|2019|718
Regulatory mechanisms of PD-1/PD-L1 in cancers
|Molecular Cancer|2024|619
Emerging role of tumor-related functional peptides encoded by lncRNA and circRNA
|Molecular Cancer|2020|578